| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.5 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |